446 related articles for article (PubMed ID: 9506756)
41. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
[TBL] [Abstract][Full Text] [Related]
42. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases.
Poncin J; Abs R; Velkeniers B; Bonduelle M; Abramowicz M; Legros JJ; Verloes A; Meurisse M; Van Gaal L; Verellen C; Koulischer L; Beckers A
Hum Mutat; 1999; 13(1):54-60. PubMed ID: 9888389
[TBL] [Abstract][Full Text] [Related]
43. Novel germline mutations of the MEN1 gene in Japanese patients with multiple endocrine neoplasia type 1.
Hamaguchi K; Nguyen DC; Yanase T; Ikuyama S; Goto K; Takayanagi R; Nawata H; Kusuda Y; Fukagawa K; Sakata T
J Hum Genet; 1999; 44(1):43-7. PubMed ID: 9929977
[TBL] [Abstract][Full Text] [Related]
44. Isolated familial somatotropinomas: clinical and genetic considerations.
Frohman LA
Trans Am Clin Climatol Assoc; 2003; 114():165-77. PubMed ID: 12813918
[TBL] [Abstract][Full Text] [Related]
45. A novel germline mutation of multiple endocrine neoplasia type 1 (MEN1) gene in a Japanese MEN1 patient and her daughter.
Ohye H; Sato M; Matsubara S; Miyauchi A; Kishi-Imai K; Murao K; Takahara J
Endocr J; 1999 Apr; 46(2):325-9. PubMed ID: 10460018
[TBL] [Abstract][Full Text] [Related]
46. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
Tahara H; Imanishi Y; Yamada T; Tsujimoto Y; Tabata T; Inoue T; Inaba M; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4113-7. PubMed ID: 11095441
[TBL] [Abstract][Full Text] [Related]
47. Multiple endocrine neoplasia type 1 (MEN1).
Thakker RV
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
[TBL] [Abstract][Full Text] [Related]
48. MEN1 gene mutations in 12 MEN1 families and their associated tumors.
Bartsch D; Kopp I; Bergenfelz A; Rieder H; Münch K; Jäger K; Deiss Y; Schudy A; Barth P; Arnold R; Rothmund M; Simon B
Eur J Endocrinol; 1998 Oct; 139(4):416-20. PubMed ID: 9820618
[TBL] [Abstract][Full Text] [Related]
49. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
[TBL] [Abstract][Full Text] [Related]
50. Mutation analysis of the MEN1 gene in Israeli patients with MEN1 and familial isolated hyperprolactinemia.
Jakobovitz-Picard O; Olchovsky D; Berezin M; Ghodsizade A; Zahavi Z; Karasik A; Rechavi G; Friedman E
Hum Mutat; 2000 Sep; 16(3):269. PubMed ID: 10980535
[TBL] [Abstract][Full Text] [Related]
51. [Familial pituitary tumors].
Yoshimoto K; Saito S
Nihon Rinsho; 1995 Nov; 53(11):2691-6. PubMed ID: 8538028
[TBL] [Abstract][Full Text] [Related]
52. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.
Klein RD; Salih S; Bessoni J; Bale AE
Genet Med; 2005 Feb; 7(2):131-8. PubMed ID: 15714081
[TBL] [Abstract][Full Text] [Related]
53. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
54. No evidence of germline mutation or somatic deletion of the MEN1 gene in a case of familial multiple endocrine neoplasia type 1 (MEN1).
Namihira H; Sato M; Matsubara S; Ohye H; Bhuiyan M; Murao K; Takahara J
Endocr J; 1999 Dec; 46(6):811-6. PubMed ID: 10724357
[TBL] [Abstract][Full Text] [Related]
55. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas.
Hessman O; Lindberg D; Skogseid B; Carling T; Hellman P; Rastad J; Akerström G; Westin G
Cancer Res; 1998 Feb; 58(3):377-9. PubMed ID: 9458074
[TBL] [Abstract][Full Text] [Related]
56. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
[TBL] [Abstract][Full Text] [Related]
57. Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
Howell VM; Cardinal JW; Richardson AL; Gimm O; Robinson BG; Marsh DJ
J Mol Diagn; 2006 Nov; 8(5):559-66. PubMed ID: 17065424
[TBL] [Abstract][Full Text] [Related]
58. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
59. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
60. 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
Weil RJ; Vortmeyer AO; Huang S; Boni R; Lubensky IA; Pack S; Marx SJ; Zhuang Z; Oldfield EH
Clin Cancer Res; 1998 Jul; 4(7):1673-8. PubMed ID: 9676841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
